© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 19, 2022
Preventive medications might be considered in patients with 4 or more migraine days per month.
January 18, 2022
More than 37 million men, women, and children in the United States are affected by migraine.
January 06, 2022
Clinicians are seeking ways to reduce opioid exposure in a variety of settings. Could the use of acetaminophen before opioid use reduce opioid treatment duration in the inpatient setting?
December 18, 2021
Take a look back at the top 10 pain management news articles published on Drug Topics® this year.
December 10, 2021
Highlights included updates on COVID-19 vaccine tolerance in individuals
with rheumatic diseases, the latest data on medical cannabis use in
fibromyalgia, and more.
December 06, 2021
Mean days of therapy per 1000 patient-days were reduced across medication categories.
December 02, 2021
A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.
December 01, 2021
By July 2021, the FDA had approved or tentatively approved 470 generic versions of medications.
November 16, 2021
Small towns have faced everything and overcome all manner of struggles—until the opioid epidemic came to town.
November 08, 2021
Pharmacists are a key part of the multidisciplinary approach that health care providers should take when tapering patients off opioid therapy.